
Carib A. Oquendo
Examiner (ID: 10644, Phone: (571)270-7411 , Office: P/3678 )
| Most Active Art Unit | 3678 |
| Art Unit(s) | 3672, 3678 |
| Total Applications | 952 |
| Issued Applications | 718 |
| Pending Applications | 72 |
| Abandoned Applications | 184 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6161234
[patent_doc_number] => 20110159496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 12/440283
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 29540
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159496.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440283
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440283 | MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA | Sep 5, 2007 | Abandoned |
Array
(
[id] => 4456902
[patent_doc_number] => 07893214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Humanized antibodies that recognize beta amyloid peptide'
[patent_app_type] => utility
[patent_app_number] => 11/842023
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 42833
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/893/07893214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11842023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842023 | Humanized antibodies that recognize beta amyloid peptide | Aug 19, 2007 | Issued |
Array
(
[id] => 4675645
[patent_doc_number] => 20080213274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY, AND NEOVASCULARIZATION CONDITIONS OF THE EYE'
[patent_app_type] => utility
[patent_app_number] => 11/841363
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 35082
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11841363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/841363 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY, AND NEOVASCULARIZATION CONDITIONS OF THE EYE | Aug 19, 2007 | Abandoned |
Array
(
[id] => 6289862
[patent_doc_number] => 20100158902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'MONOCLONAL ANTIBODIES AGAINST STROMAL DERIVED FACTOR-1 (SDF-1)'
[patent_app_type] => utility
[patent_app_number] => 12/377015
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 37654
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158902.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377015
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377015 | Monoclonal antibodies against stromal derived factor-1 (SDF-1) | Aug 9, 2007 | Issued |
Array
(
[id] => 5464401
[patent_doc_number] => 20090324601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/376052
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 154284
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324601.pdf
[firstpage_image] =>[orig_patent_app_number] => 12376052
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/376052 | TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF | Aug 1, 2007 | Abandoned |
Array
(
[id] => 4704523
[patent_doc_number] => 20080064047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS'
[patent_app_type] => utility
[patent_app_number] => 11/829323
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12166
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11829323
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/829323 | METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS | Jul 26, 2007 | Abandoned |
Array
(
[id] => 4745258
[patent_doc_number] => 20080089860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Therapeutic compositions and methods useful in treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/812471
[patent_app_country] => US
[patent_app_date] => 2007-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 43891
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089860.pdf
[firstpage_image] =>[orig_patent_app_number] => 11812471
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/812471 | Therapeutic compositions and methods useful in treating cancer | Jun 18, 2007 | Abandoned |
Array
(
[id] => 5125489
[patent_doc_number] => 20070237760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Detection and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/811590
[patent_app_country] => US
[patent_app_date] => 2007-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10288
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237760.pdf
[firstpage_image] =>[orig_patent_app_number] => 11811590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/811590 | Detection and treatment of cancer | Jun 10, 2007 | Abandoned |
Array
(
[id] => 7724433
[patent_doc_number] => 08097704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-17
[patent_title] => 'Antibody specifically binding to DR5 and composition for preventing or treating cancers comprising the same'
[patent_app_type] => utility
[patent_app_number] => 12/307293
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 38
[patent_no_of_words] => 8292
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097704.pdf
[firstpage_image] =>[orig_patent_app_number] => 12307293
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307293 | Antibody specifically binding to DR5 and composition for preventing or treating cancers comprising the same | May 30, 2007 | Issued |
Array
(
[id] => 7595450
[patent_doc_number] => 07626011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-01
[patent_title] => 'Antibodies against tumor surface antigens'
[patent_app_type] => utility
[patent_app_number] => 11/802989
[patent_app_country] => US
[patent_app_date] => 2007-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 25206
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/626/07626011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11802989
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/802989 | Antibodies against tumor surface antigens | May 28, 2007 | Issued |
Array
(
[id] => 4555349
[patent_doc_number] => 07842291
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-11-30
[patent_title] => 'Methods and compositions for diagnosing and treating diseases'
[patent_app_type] => utility
[patent_app_number] => 11/802321
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 41111
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842291.pdf
[firstpage_image] =>[orig_patent_app_number] => 11802321
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/802321 | Methods and compositions for diagnosing and treating diseases | May 21, 2007 | Issued |
| 10/565751 | Engineered and Energized Fusion Protein Fv-Ldp-Ae With Potent Antitumor Efficacy and Antiangiogenic Activity and Use Thereof | May 2, 2007 | Abandoned |
Array
(
[id] => 4859127
[patent_doc_number] => 20080267977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Combined immunological agent and sensitizing agent for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/796517
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9036
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267977.pdf
[firstpage_image] =>[orig_patent_app_number] => 11796517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/796517 | Combined immunological agent and sensitizing agent for the treatment of cancer | Apr 25, 2007 | Abandoned |
Array
(
[id] => 5209955
[patent_doc_number] => 20070248539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'AgRM2 antigen'
[patent_app_type] => utility
[patent_app_number] => 11/789376
[patent_app_country] => US
[patent_app_date] => 2007-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17547
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248539.pdf
[firstpage_image] =>[orig_patent_app_number] => 11789376
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/789376 | AgRM2 antigen | Apr 22, 2007 | Abandoned |
Array
(
[id] => 4443831
[patent_doc_number] => 07862812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Methods for decreasing immune response and treating immune conditions'
[patent_app_type] => utility
[patent_app_number] => 11/784417
[patent_app_country] => US
[patent_app_date] => 2007-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20036
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/862/07862812.pdf
[firstpage_image] =>[orig_patent_app_number] => 11784417
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/784417 | Methods for decreasing immune response and treating immune conditions | Apr 5, 2007 | Issued |
Array
(
[id] => 16925322
[patent_doc_number] => 11046784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Methods for controlling blood pharmacokinetics of antibodies
[patent_app_type] => utility
[patent_app_number] => 12/295039
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17658
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12295039
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295039 | Methods for controlling blood pharmacokinetics of antibodies | Mar 29, 2007 | Issued |
Array
(
[id] => 5198665
[patent_doc_number] => 20070297983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Inhibition of breast carcinoma stem cell growth and metastasis'
[patent_app_type] => utility
[patent_app_number] => 11/724884
[patent_app_country] => US
[patent_app_date] => 2007-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4421
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20070297983.pdf
[firstpage_image] =>[orig_patent_app_number] => 11724884
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/724884 | Inhibition of breast carcinoma stem cell growth and metastasis | Mar 15, 2007 | Abandoned |
Array
(
[id] => 216795
[patent_doc_number] => 07611703
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-11-03
[patent_title] => 'Kidney disease targets and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/717149
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42469
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/611/07611703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11717149
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/717149 | Kidney disease targets and uses thereof | Mar 12, 2007 | Issued |
Array
(
[id] => 7593512
[patent_doc_number] => 07651687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-26
[patent_title] => 'Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/717545
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 77548
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/651/07651687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11717545
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/717545 | Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors | Mar 12, 2007 | Issued |
Array
(
[id] => 4669779
[patent_doc_number] => 20080044839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Methods and compositions for diagnosing lung cancer'
[patent_app_type] => utility
[patent_app_number] => 11/715642
[patent_app_country] => US
[patent_app_date] => 2007-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 41543
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044839.pdf
[firstpage_image] =>[orig_patent_app_number] => 11715642
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/715642 | Methods and compositions for diagnosing lung cancer | Mar 7, 2007 | Issued |